Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

53%


Total
Publications

980


Total Open
Publications

515


Total
Citations

37K


Open Access
Percentage

53%


Total
Publications

980


Total Open
Publications

515


Total
Citations

37K

Wikipedia

Website

download

Breakdown

16% 32% 5% 47%

Publisher Open

16%

Both

32%

Other Platform Open

5%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

213

Hybrid 27%

128

No Guarantees 27%

125

Other Platform Open

Domain 79%

285

Institution 26%

95

Other Internet 14%

50

Preprint 4%

16

Public 1%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
287
DOI
Other Internet
48
Royal Netherlands Academy of Arts and Sciences
Institution
30
Europe PMC
Domain
17
King's College London
Institution
13
Ghent University
Institution
11
Universidad Autónoma de Madrid
Institution
9
uniroma1.it OAI-PMH Repository
Institution
9
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
Research Square
Preprint
7
1 / 6

Data updated 18 August 2025

Share

Share

Share